MaxCyte, Inc. - stock earnings
MXCT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -11.3 million USD | 8.0 million USD |
| 2023Q2 | -10.5 million USD | 9.0 million USD |
| 2023Q1 | -8.6 million USD | 8.6 million USD |
| 2022Q4 | -2.9 million USD | 12.4 million USD |
| 2022Q3 | -5.2 million USD | 10.6 million USD |
| 2022Q2 | -7.8 million USD | 9.6 million USD |
| 2022Q1 | -4.0 million USD | 11.6 million USD |
| 2021Q4 | -4.9 million USD | 10.2 million USD |
| 2021Q3 | -2.7 million USD | 10.1 million USD |
| 2021Q2 | -4.4 million USD | 7.1 million USD |
| 2021Q1 | -7.1 million USD | 6.5 million USD |
| 2020Q4 | -2.7 million USD | 8.5 million USD |
| 2020Q3 | -3.1 million USD | 6.8 million USD |
| 2020Q2 | -3.0 million USD | 5.2 million USD |
MXCT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -37.5 million USD | 38.0 million USD |
| 2022 | -19.8 million USD | 44.3 million USD |
| 2021 | -20.1 million USD | 33.9 million USD |
| 2020 | -12.6 million USD | 26.2 million USD |
| 2019 | -13.6 million USD | 21.6 million USD |
| 2018 | -8.9 million USD | 16.7 million USD |
| 2017 | -9.9 million USD | 14.0 million USD |
| 2016 | -3.3 million USD | 12.3 million USD |
| 2015 | -1.4 million USD | 9.3 million USD |
| 2014 | -1.8 million USD | 7.2 million USD |
| 2013 | -958200 USD | 6.8 million USD |
| 2012 | -2.0 million USD | 5.1 million USD |
MXCT
Price: $3.83
52 week price:
Earnings Per Share: -0.37 USD
P/E Ratio: -13.22
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 508900
Market Capitalization: 429.8 million